Sage Journals: Discover world-class research

Open access

Research article

First published 2021

Olaratumab’s failure in soft tissue sarcoma

Maroun Bou Zerdan, Aram H Bidikian, Ibrahim Alameh [...]

Rare Tumors

Retricted access

Review article

First published 2019-3

Olaratumab in the management of advanced soft tissue sarcoma

Chrystia M Zobniw, Van Anh Trinh, Kristi Posey [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2017-12

Olaratumab: A Novel Platelet-Derived Growth Factor Receptor α-Inhibitor for Advanced Soft Tissue Sarcoma

Benjamin J. Andrick, Arpita Gandhi

Annals of Pharmacotherapy

Retricted access

Other

First published 2017-4

Drug Monographs: Olaratumab and Rucaparib

Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Retricted access

Other

First published 2017-4

Drug Monographs: Olaratumab and Rucaparib

Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Open access

Review article

First published 2017-8

Treatment of advanced,metastatic soft tissue sarcoma: latest evidence and clinical considerations

Gino K. In, James S. Hu, William W. Tseng

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022-04

Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial

Brian A Van Tine, Anders Krarup-Hansen, Lisa M Hess [...]

Rare Tumors

Retricted access

Research article

First published 2017-1

Lixisenatide

Danial E. Baker, Terri L. Levien

Hospital Pharmacy

Search results